Current Medicinal Chemistry
Title:Biomarkers in Migraine Headache: Prognostic and Therapeutic Implications
Volume: 26 Issue: 34
Author(s): Patrizia Ferroni and Piero Barbanti
Affiliation:
Export Options
About this article
Cite this article as:
Ferroni Patrizia and Barbanti Piero , Biomarkers in Migraine Headache: Prognostic and Therapeutic Implications, Current Medicinal Chemistry 2019; 26 (34) . https://dx.doi.org/10.2174/092986732634191112142448
DOI https://dx.doi.org/10.2174/092986732634191112142448 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
24
5
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Green and Highly Efficient One-Pot Synthesis of Some New Bis Thiazolidinones
Letters in Organic Chemistry Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer’s Disease in the Transgenic CRND8 Mice
Current Alzheimer Research Can We Detect Psychotic-like Experiences in the General Population?
Current Pharmaceutical Design Plasma Level of D-dimer is an Independent Diagnostic Biomarker for Deep Venous Thrombosis in Patients with Ischemic Stroke
Current Neurovascular Research Alzheimer's Disease and the Routine Clinical Use of CSF Biomarkers
CNS & Neurological Disorders - Drug Targets Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?
Current Pharmaceutical Design Editorial: [Hot Topics: A New Horizon of Herbal Medicines in Anorexia-Cachexia Syndrome]
Current Pharmaceutical Design Plant Polyphenols: Natural and Potent UV-Protective Agents for the Prevention and Treatment of Skin Disorders
Mini-Reviews in Medicinal Chemistry Commentary Research Highlights: Adaptive PTEN Loss Enhances the Outgrowth of Brain Metastatic Tumour Cells
CNS & Neurological Disorders - Drug Targets GABAergic Contributions to the Pathophysiology of Depression and the Mechanism of Antidepressant Action
CNS & Neurological Disorders - Drug Targets Current Knowledge on the Antagonists and Inverse Agonists of Cannabinoid Receptors
Current Medicinal Chemistry Transition Metal Complexes of Some Azamacrocycles and Their Use in Molecular Recognition
Current Organic Synthesis Understanding Cardiotocography: Technical Aspects
Current Women`s Health Reviews Research Progress of Essential Oil as a New Complementary Therapy in the Treatment of Depression
Mini-Reviews in Medicinal Chemistry Low Density Lipoprotein Receptor-Related Proteins (LRPs), Alzheimers and Cognition
Current Drug Targets - CNS & Neurological Disorders Triiodothyronine (T3) Effects on Cardiovascular System in Patients with Heart Failure
Recent Patents on Cardiovascular Drug Discovery Synthesis, Biological Evaluation and in silico Studies of Novel 5α-aza-Bhomo-3,5-secosteroids as Potential 5-reductase Inhibitors
Letters in Drug Design & Discovery Neurotrophic Factors as a Protective Strategy in Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Drug Design for Protein Kinases and Phosphatases: Flexible-Receptor Docking, Binding Affinity and Specificity, and Drug-Binding Kinetics
Current Pharmaceutical Design Protein Aggregation and Defective RNA Metabolism as Mechanisms for Motor Neuron Damage
CNS & Neurological Disorders - Drug Targets